Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

With more than 170 million individuals currently infected, HCV is a global pandemic, effecting approximately 3% of the entire world's population. HCV infection is a growing infectious disease pandemic ...

Women who were prescribed direct-acting antivirals prior to hospital discharge were more likely to complete their regimens.

Osaka, Japan - Hepatitis C virus (HCV) may cause chronic infection to the liver, which can result in irreversible liver damage and liver cancer. How HCV manages to evade the immune system to infect ...

Unlike HIV or HBV, HCV replicates its genome directly into RNA without a DNA intermediate, so it lacks a latent, nuclear form that defies ready immunological clearance. In order for the virus to exist ...

Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...

Providing immediate bedside hepatitis C virus (HCV) consultation at discharge from labor and delivery for women with HCV-affected pregnancies is associated with higher rates of treatment completion ...

Pelosi is a scientific manager and researcher. Perkins is a senior advisor in governance. Remak is a patient advocate. Seid is a vaccine program lead. Romanowska is a fact-checking expert addressing ...

Public comment period opens for proposed Medicaid work requirements. Chippewa Cree Tribe awarded $2.5 million for hepatitis C ...

Patients visiting emergency departments in the Humber region will be tested for serious infections under a new initiative. All adults who have blood taken as part of their treatment will have the ...